Warning letterFDA · Nov 14, 2022
Anabolic Laboratories Inc MARCS-CMS 636308, November 14, 2022
Named company: Anabolic Laboratories Inc
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, CoQ10 Ubiquinol Prime fails to bear adequate…
